enGene Holdings Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
6.90
-0.41 (-5.61%)
At close: Mar 24, 2026, 4:00 PM EDT
6.88
-0.02 (-0.28%)
After-hours: Mar 24, 2026, 6:19 PM EDT
enGene Holdings Employees
As of October 31, 2025, enGene Holdings had 82 total employees, including 81 full-time and 1 part-time employees. The number of employees increased by 25 or 43.86% compared to the previous year.
Employees
82
Change (1Y)
25
Growth (1Y)
43.86%
Revenue / Employee
n/a
Profits / Employee
-$1,493,146
Market Cap
462.23M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Oct 31, 2025 | 82 | 25 | 43.86% | 81 | 1 |
| Oct 31, 2024 | 57 | 24 | 72.73% | 56 | 1 |
| Oct 31, 2023 | 33 | - | - | 31 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| Rocket Pharmaceuticals | 202 |
| 4D Molecular Therapeutics | 196 |
| ADC Therapeutics | 193 |
| CorMedix | 191 |
| Rigel Pharmaceuticals | 174 |
| Nautilus Biotechnology | 130 |
| Verastem | 102 |
| Larimar Therapeutics | 71 |
ENGN News
- 12 days ago - enGene Holdings: Key Catalysts Incoming For 2026 - Seeking Alpha
- 14 days ago - enGene Holdings Inc. (ENGN) Presents at Barclays 28th Annual Global Healthcare Conference Transcript - Seeking Alpha
- 15 days ago - enGene Reports First Quarter 2026 Financial Results and Provides Business Update - Business Wire
- 4 weeks ago - enGene to Participate in Upcoming Investor Conferences - Business Wire
- 6 weeks ago - enGene to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 - Business Wire
- 2 months ago - enGene: Two Major Catalysts On Deck For 2nd Half Of 2026 - Seeking Alpha
- 2 months ago - enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc. - Business Wire
- 3 months ago - enGene Reports Full Year 2025 Financial Results and Provides Business Update - Business Wire